These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7037373)

  • 1. Glucose-induced hyperkalemia in normaldosteronemic diabetes associated with hyperthyroidism.
    Radó JP
    Endokrinologie; 1981 Dec; 78(2-3):239-43. PubMed ID: 7037373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of glucose-induced hyperkalemia by sodium restriction in normaldosteronemic diabetes: evidence for elevated mineralocorticoid threshold.
    Rado JP
    Biomedicine; 1981 Sep; 35(4):109-11. PubMed ID: 7295860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of glucose-induced hyperkalemia by sodium restriction in "normaldosteronemic" diabetes mellitus.
    Radó JP
    Endokrinologie; 1981 Dec; 78(2-3):244-52. PubMed ID: 7037374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible role for human growth hormone (HGH) in the protection from glucose-induced hyperkalemia in normaldosteronemic diabetes.
    Radó JP
    Endokrinologie; 1982 Nov; 80(3):364-6. PubMed ID: 7166165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of plasma aldosterone by glucose-induced paradoxical hyperkalemia in the presence of suppressed renin-angiotensin system.
    Radó JP
    Endokrinologie; 1978 Apr; 72(1):51-6. PubMed ID: 688983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.
    Radó JP
    J Endocrinol Invest; 1979; 2(4):401-6. PubMed ID: 395185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay of various factors in glucose-induced hyperkalemia during captopril treatment.
    Radó JP; Gercsák G; Bános C
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):69-76. PubMed ID: 3514489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mineralocorticoids on the paradoxical glucose-induced hyperkalemia in nondiabetic patients with selective hypoaldosteronism.
    Rado JP
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):365-8. PubMed ID: 918352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-induced hyperkalemia in diabetic subjects.
    Nicolis GL; Kahn T; Sanchez A; Gabrilove JL
    Arch Intern Med; 1981 Jan; 141(1):49-53. PubMed ID: 7447584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Big renin and biosynthetic defect of aldosterone in diabetes mellitus.
    deLeiva A; Christlieb AR; Melby JC; Graham CA; Day RP; Luetscher JA; Zager PG
    N Engl J Med; 1976 Sep; 295(12):639-43. PubMed ID: 184384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of hyperkalemia associated with prolonged treatment with captopril by glucose-induced acute serum potassium changes.
    Radó JP
    Exp Clin Endocrinol; 1984 Oct; 84(2):143-7. PubMed ID: 6396097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study.
    Koren-Michowitz M; Avni B; Michowitz Y; Moravski G; Efrati S; Golik A
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):299-302. PubMed ID: 15133781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-induced hyperkalemia developing in the upright position in captopril-treated hypertensives.
    Radó JP; Bános C; Gercsák G; Molnár Z; Pató E; Csabuda M
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):161-4. PubMed ID: 6755590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of hyperkalemic quadriplegia associated with spironolactone.
    Radó JP
    Int J Clin Pharmacol Ther Toxicol; 1988 Jul; 26(7):339-45. PubMed ID: 3061940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Outpatient hyperkalemia" syndrome in renal and hypertensive patients with suppressed aldosterone production.
    Rado JP; Boer P; Dorhout Mees EJ; Simatupang T
    J Med; 1979; 10(3):145-57. PubMed ID: 289714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renin-angiotensin-aldosterone system in diabetic patients with hyperkalemia.
    Sunderlin FS; Anderson GH; Streeten DH; Blumenthal SA
    Diabetes; 1981 Apr; 30(4):335-40. PubMed ID: 7009278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperkalemia associated with indomethacin.
    Goldszer RC; Coodley EL; Rosner MJ; Simons WM; Schwartz AB
    Arch Intern Med; 1981 May; 141(6):802-4. PubMed ID: 7016059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural plasma aldosterone response in "upright hyperkalemia" associated with selective hypoaldosteronism.
    Rado JP; Simatupang T; Boer P; Dorhout Mees EJ
    Biomedicine; 1977 Jul; 27(6):209-11. PubMed ID: 907798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical glucose-induced hyperkalemia. Combined aldosterone-insulin deficiency.
    Goldfarb S; Strunk B; Singer I; Goldberg M
    Am J Med; 1975 Nov; 59(5):744-50. PubMed ID: 1200041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.